
Open to all immunology enthusiasts !
A club that brings together autoimmunity and cancer, two worlds linked by one bridge.
Welcome to the Transdisciplinary Immunology Journal Club (TIJC) — your global hub for cutting-edge immunology, cross-disciplinary insights, and career development. TIJC unites physicians, researchers, and students worldwide to explore breakthroughs in immunology, oncology, autoimmunity, and translational medicine.
Featured Sessions
| TITLE | SPEAKER | DATE (CET) / REPLAY |
|---|---|---|
| TBC | Manon Lesturgie Talarek | September ?, 2026 – 16h |
| TBC | Joline Ingels | June 18, 2026 – 16h |
| TBC | Francesca Lucibello | May 6, 2026 – 15h |
| Location-Specific T-cell Inhibitory Molecules (LoSTIMs) for targeted immunosuppression | James Torchia | April 23, 2026 – 16h |
| Emerging Roles of Endogenous Retroelements in Immunity From tissue senescence to regulation of adaptive immune responses , targeting retroelements as a strategy to mitigate immune-mediated diseases | Nader Yatim | March 26, 2026 – 15h |
| Innate immune dysfunction in VEXAS syndrome | Paul Breillat | Feb 12, 2026 – 16h |
| Aging, Immunosenescence & Immunotherapies | Marie Naigeon | n/a |
| Accelerating Cancer Immunotherapy Research (ACIR) | Ute Burkhardt & Ed Fritsch | Watch Replay |
| CD19 CAR T Cell Therapy in Multidrug Resistant Ulcerative Colitis (NEJM 2025) | Antoine Meyer | Watch Replay |
| High endothelial venules (HEVs): specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy | Lucas Blanchard | Watch Replay |
| NK Cells Restrict CD8+ T Cells in Submandibular Gland via PD-1–PD-L1 + irAE Colitis | David Zemmour | Watch Replay |
| Organoid Co-Culture Model for Systemic Anti-Tumor Immunity in Lung Cancer | Negaar Goudarzi | Postponed |
| Anti-PD-1 Amplifies Co-Stimulation in Melanoma-Infiltrating Th1-like Foxp3+ Tregs | Mikhaël Attias | Watch Replay |
| HLA Class I Peptide Polymorphisms and Antibody Specificity | Cédric Usureau | Watch Replay |
| Evolution of Myeloid-Mediated Immunotherapy Resistance in Prostate Cancer | Simon Coiba | Watch Replay |
| Neoantigen Vaccines in Precision Oncology | Adrien Mouren | Watch Replay |
| Rapid Establishment of CD8+ T Cell Dysfunction upon Tumor Antigen Encounter | Matthieu Roulleau Dugage | Watch Replay |
| Disrupting Antitumor Immune Axis by Targeting CD206+ Macrophages | Marie Robert | Watch Replay |
| Revitalizing Exhausted CD8+ T Cells with Fc–IL-4 | François-Xavier Danlos | Watch Replay |
| JAK Inhibitors and Cancer: Friend or Foe? | Samuel Bitoun | Watch Replay |
➡ Watch all Replays below
➡ Follow us on LinkedIn to never miss a session !
TIJC videos are hosted on YouTube. Viewing these videos implies acceptance of the YouTube API Terms of Service.


12 Feb 2026
Innate immune dysfunction in VEXAS: mechanisms of inflammation and infection risk #tijc


Accelerating Cancer Immunotherapy Research (ACIR) – journal club #tijc


CD19 CAR TCell Therapy in MultidrugResistant Ulcerative Colitis (NEJM 2025) – Journal Club #tijc


HEVs : specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy #tijc


NK cells regulate CD8+ T cells via PD 1PD L1 & Immunotherapy Induced Colitis – Journal Club #tijc


CD8+ T Cell Dysfunction Begins Hours After Tumor Antigen Exposure – Journal Club #tijc


Evolution of myeloid mediated immunotherapy resistance in prostate cancer – Journal Club #tijc


Neoantigen vaccines a new era of precision medicine in oncology – Journal Club #tijc


Tregs & Anti PD 1 #TIJC – Journal Club #tijc


HLA Class I Peptide Polymorphisms and Antibody Specificity – Journal Club #tijc


Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis #tijc


The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancer – Journal Club #tijc


JAK Inhibitors and Cancer: Friend or Foe? Dr Samuel Bitoun – Journal Club #tijc




